This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Yushi Xiao: Innovator in A2A-Receptor Antagonists
Introduction: Yushi Xiao is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as A2A-receptor antagonists. His work is essential in advancing medical science and improving therapeutic options.
Latest Patents: Yushi Xiao holds 1 patent related to his innovative work. The patent is directed to compounds of generic formula I, or pharmaceutically acceptable salts thereof, which are believed to be useful as an A2A-receptor antagonist. This invention has the potential to impact various therapeutic areas.
Career Highlights: Yushi Xiao is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role at Merck allows him to collaborate with other talented professionals and contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations: Throughout his career, Yushi has worked alongside esteemed colleagues such as Pauline C Ting and Jianhua Cao. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.
Conclusion: Yushi Xiao's contributions to the field of pharmaceuticals, particularly through his patent on A2A-receptor antagonists, highlight his role as an influential inventor. His work at Merck Sharp & Dohme Corp. and collaborations with other professionals further emphasize his commitment to advancing medical science.